Device
senofilcon C
senofilcon C is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Clinical Study of Approved Contact Lenses
NCT03351101
completednot_applicable
Performance Comparison Between Comfilcon A and Senofilcon C Lenses
NCT02920957
completednot_applicable
Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses
NCT02625233
completednot_applicable
Evaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact Lens
NCT02515994
Clinical Trials (4)
Showing 4 of 4 trials
NCT03351101Not Applicable
Clinical Study of Approved Contact Lenses
NCT02920957Not Applicable
Performance Comparison Between Comfilcon A and Senofilcon C Lenses
NCT02625233Not Applicable
Clinical Long-Term Evaluation of Approved and Investigational Contact Lenses
NCT02515994Not Applicable
Evaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact Lens
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4